Q3 2023 Seres Therapeutics Inc Earnings Call Transcript
Welcome to the Seres Therapeutics Third Quarter 2023 Financial Results Conference Call. (Operator Instructions) Please note, this event is being recorded.
I would now like to turn the conference over to Kevin Mannix, Head of Investor Relations. Please go ahead.
Thank you, Dave, and good morning, everyone. Our press release for the company's third quarter 2023 financial results and business update became available at 7:00 a.m. Eastern Time this morning and can be found on the Investor and News section of the company's website.
I'd like to remind you that we'll be making forward-looking statements, including the availability of cash to fund operations, the potential sales for VOWST, the timing and results of clinical studies, our ability to achieve sales targets, and other statements, which are not historical fact. Actual results may differ materially.
Additionally, these statements are subject to certain risks and uncertainties, which are discussed under the Risk Factors section of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |